View Profile

Rehab Mohamed Elgharabawy

Pharmacology and Toxicology · Faculty of Pharmacy, Tanta University

https://researchid.co/r.elgharabawy
@tdb2.tanta.edu.eg
32Scopus Publications
1286Google Scholar Citations
22Google Scholar h-index
31Google Scholar i10-index

Recent Scopus Publications

  1. Retraction notice to "Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling"(Biomedicine & Pharmacotherapy, (2023), 158, C, (114196), (S0753332222015852), 10.1016/j.biopha.2022.114196)
    Biomedicine and Pharmacotherapy, 2026
  2. Mirtazepine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model
    Biomedicine and Pharmacotherapy, 2023
  3. Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
    Biomedicine and Pharmacotherapy, 2023
  4. Alanda (Ephedra foeminea) nanoparticles as a modulator of genomic DNA degradation in mice: new inspiration for treating Ehrlich solid tumour-induced kidney and liver toxicity
    European Review for Medical and Pharmacological Sciences, 2023
  5. Suppressing NLRP3 activation and PI3K/AKT/mTOR signaling ameliorates amiodarone-induced pulmonary fibrosis in rats: a possible protective role of nobiletin
    Inflammopharmacology, 2023

Links